In contrast, in an elegant study aimed at uncovering the key epigenetic regulators that promote CRC cell growth, McCleland and colleagues showed that inhibition of BRD4 by JQ1 reduced MYC expression in cancer cells and led to a preferential reduction of the growth of a subset of epigenetically dysregulated CIMP-positive CRC. Here, BRD4 is linked to colorectal carcinoma.